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Abstract
Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a multifunctional enzyme that is 
required for synaptic plasticity and has been proposed to be a primary molecular component of the 
etiology of alcohol addiction. Chronic alcohol intake upregulates CaMKIIα protein expression in 
reward-related brain regions including the amygdala and nucleus accumbens, and CaMKIIα 
activity in the amygdala is required for the positive reinforcing effects of alcohol, suggesting this 
system promotes consumption in the early stages of alcohol addiction. Alternatively, the medial 
prefrontal cortex (mPFC) is known to inhibit limbic activity via CaMKII-dependent excitatory 
projections and may, therefore, enable top-down regulation of motivation. Here we sought to 
remove that regulatory control by site-specifically inhibiting CaMKII activity in the mPFC, and 
measured effects on the positive reinforcing effects of sweetened alcohol in C57BL/6J mice. 
Infusion of the CAMKII inhibitor KN-93 (0–10.0 μg) in the mPFC primarily increased alcohol
+sucrose reinforced response rate in a dose- and time-dependent manner. KN-93 infusion reduced 
response rate in behavior-matched sucrose-only controls. Importantly, potentiation of operant 
responding for sweetened alcohol occurred immediately after infusion, at a time during which 
effects on sucrose responding were not observed, and persisted through the session. These results 
suggest that endogenous CaMKII activity in the mPFC exerts inhibitory control over the positive 
reinforcing effects of alcohol. Downregulation of CaMKII signaling in the mPFC might contribute 
to escalated alcohol use.
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Alcohol dependence is a complex neuropsychiatric disorder that afflicts more than 9% of the 
total US population. Epidemiological studies suggest that a majority of individuals (52%) 
actively engage in moderate, or sub-dependent, levels of alcohol drinking at amounts that 
are capable of inducing widespread changes in fundamental neural systems that normally 
regulate cognition, motivation, and other adaptive functions of the organism [1, 2]. For 
example, recent evidence indicates that moderate drinking launches a cascade of 
neuroadaptations in the amygdala proteome, linked to calcium/calmodulin-dependent 
protein kinase II (CaMKII), that mechanistically drive the positive reinforcing effects of 
alcohol and may serve, therefore, as a molecular pathway from use to abuse [3]. Thus, 
elucidating the neural mechanisms that regulate alcohol consumption in the non-dependent 
state is critical for a comprehensive understanding of the etiology of addiction.
CaMKII is a family of Ca2+-activated Ser/Thr protein kinases that mediates many 
intracellular responses in the brain including regulation of membrane current, 
neurotransmitter synthesis and release, cytoskeletal organization, and synaptic plasticity [4, 
5]. CaMKII is activated when neuronal depolarization leads to Ca2+ entry into the cell 
through multiple sources including ionotropic glutamate receptors (calcium-permeable 
AMPA and NMDA receptors), L-type voltage-gated calcium channels, and via release from 
internal stores. Following activation, CaMKII translocate to the membrane and/or 
postsynaptic density where it regulates receptor (i.e., NMDA, AMPA) activity [6]. 
Importantly, a number of CaMKII interacting proteins, including NMDA and AMPA 
receptors, PSD proteins, CREB, and the MAPKs regulate alcohol-related behaviors 
including self-administration and relapse (e.g.,[7-10]). Thus, CaMKII may represent a 
molecular point of convergence in the regulation of maladaptive behaviors associated with 
alcohol abuse.
Emerging evidence indicates that CAMKII activity and function are altered by alcohol in 
reward-related brain regions. Increases in CaMKII protein expression and activation (e.g., 
phosphorylation) have been reported in the cortex, nucleus accumbens and amygdala 
following alcohol dependence as well as by moderate, or non-dependent, levels induced by 
voluntary drinking or operant self-administration [3, 11-13]. The functional importance of 
CAMKII on alcohol-associated behaviors has been recently studied using both 
pharmacological and genetic approaches. CaMKIIα autophosphorylation-deficient mice 
show reduced alcohol consumption and preference and have a blunted response to the 
locomotor-stimulating effects of alcohol [14]. We have shown that the positive reinforcing 
effects of sweetened alcohol require CaMKII activity in the amygdala [3] but the complete 
neural circuitry of CaMKII-dependent regulation of alcohol-seeking behavior remains to be 
fully characterized.
Behavioral pathologies in addiction, such as exacerbated drug-seeking behavior, represent a 
dynamic interplay between heightened motivation and cognitive regulatory processes that 
control goal-directed behaviors. Under normal conditions, the medial prefrontal cortex 
(mPFC) exerts “top-down” control over limbic motivational systems via CaMKII-positive 
glutamatergic projections to brain regions, such as the nucleus accumbens and amygdala. 
However, repeated drug use is thought to result in PFC dysregulation, loss of executive 
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control, and exacerbated drug use due to impaired response inhibition [15]. Although 
evidence cited above implicates CaMKII signaling in the rewarding and reinforcing effects 
of alcohol, the role of this critical cell signaling molecule in the PFC remains unknown. To 
address this gap in knowledge, the objective of the current experiment was to determine if 
CaMKII activity in the mPFC mechanistically regulates the positive reinforcing effects of 
alcohol. If the mPFC exerts top-down regulatory control of behavioral pathologies in alcohol 
addiction via response inhibition, we predicted that blockade of CaMKII activity in the 
mPFC would increase, or exacerbate, sweetened alcohol self-administration via increased 
positive reinforcement function. Given the prominence of CaMKII signaling in the 
development and regulation of new behavior, these findings will provide novel information 
on how alcohol may gain control over behavior during the early stages of addiction when 
drug use is primarily driven by positive reinforcement.
Male C57BL/6J mice (10-wks old; n=40) were obtained from Jackson Laboratory (Bar 
Harbor, ME). Mice were group-housed and initially handled for 7 days (Figure 1A). Food 
and water were freely available unless noted. The vivarium was maintained on a reverse 
12:12 light/dark schedule, with average temperature and humidity of 25°C and 40%, 
respectively. All protocols were conducted in accordance with the Institutional Animal Care 
and Use Committee of the University of North Carolina-Chapel Hill and the Guide for the 
Care and Use of Laboratory Animals.
Self-administration studies were conducted as described [3]. One week after arrival, separate 
groups of mice were presented with a 9% alcohol (v/v)/2% sucrose (w/v) (Alcohol + 
Sucrose; Pharmco-AAPER, Shelbyville, KY) or 2% Sucrose (w/v; Sucrose-only) solution, 
along with water, in their home-cage for 2 weeks (Figure 1A). Home-cage exposure 
facilitates operant self-administration training [16]. After home-cage self-administration, 
mice were water restricted for 20-hrs and then placed into an operant conditioning chamber 
for a 16-hr overnight session during which lever press responses were reinforced with 
delivery of either Alcohol+Sucrose or sucrose-only. All conditioning occurred in sound-
attenuating chambers (Med Associates; St.Albans, VT) containing retractable levers. Only 
responding on the active lever was reinforced. After 3 overnight sessions, mice were no 
longer water restricted and training was shortened to 1-hr sessions (Figure 1A). Throughout 
the remainder of the experiment, the response requirement was maintained at a fixed-ratio 4 
schedule of reinforcement. Blood was collected after surgery on the 87th self-administration 
session via submandibular bleed and plasma alcohol levels were measured using an AM1 
Alcohol Analyzer (Analox Instruments, Ltd., Lunenburg, MA;[7];Figure 1A).
After 45 sessions (Figure 1A), mice were anesthetized with ketamine (120 mg/kg,i.p.) and 
xylazine (9 mg/kg,i.p.), placed into a stereotaxic frame (Kopf Instruments, Tujunga, CA), 
and implanted with a 26-gauge guide cannula (Plastics One, Roanoke, VA) unilaterally 
aimed at either the right or the left mPFC (AP +1.7mm; ML ±0.4mm; DV −1.2mm, from 
skull surface [3, 17]. The guide cannula was secured to the skull with dental cement 
(Durelon, Butler Schein, Dublin, OH) and a 33-gauge obturator was inserted. After 1 week 
of recovery, alcohol+sucrose and sucrose-only self-administration sessions resumed. During 
baseline, alcohol+sucrose self-administering mice consumed pharmacologically significant 
doses of sweetened alcohol (Mean±SEM = 0.97±0.15 g/kg). Dose consumed on DAY 87 
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(Mean±SEM = 1.06 ± 0.26 g/kg) was positively correlated with BAC (34.7mg/dl±14.2) at 
the end of the 1-hr session (r2=0.749;Figure 1B). Alcohol+sucrose and sucrose-only groups 
were behavior-matched on total responses during self-administration sessions before (data 
not shown) and after surgery (Figure 1E and 1H, aCSF bars) indicating that KN-93 drug 
effects were not related to basal performance.
The selective CAMKII inhibitor KN-93 ( N-[2-[[[3-(4-Chlorophenyl)-2-
propenyl]methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-
methoxybenzenesulphonamide phosphate; Tocris Bioscience, Bristol, UK) was administered 
via site-specific microinjection. Mice were habituated to handing, and sham microinjections 
were conducted prior to sessions until stable levels of responding were observed (ca. 3 sham 
injections). Next, a within-subjects dose-effect curve for the CAMKII inhibitor, KN-93, was 
conducted in a counterbalanced design (n=9 for alcohol + sucrose; n=11 for sucrose-only 
mice). KN-93 (artificial cerebrospinal fluid, aCSF; 0.3-10 μg/injection; 4 injections/mouse) 
was infused into the mPFC of unrestrained mice (0.5 μl/injection; 0.125μl/min; 33-gauge 
injector extended 2mm beyond the tip of the guide cannula). After the infusion, mice were 
immediately placed into the operant chamber for a 1-hr self-administration session. 
Injections occurred 2x/week. Immediately after the final session, mice were deeply 
anesthetized with sodium pentobarbital (150mg/kg) and intracardially perfused with 0.9% 
phosphate buffered saline and 4% paraformaldehyde for histological verification of injection 
site (Figure 1C). Three mice were excluded from analysis due to missed cannula placement.
Mice that did not reliably self-administer alcohol+sucrose or sucrose-only after surgery were 
used to test the effects of KN-93 on locomotor activity as an index of non-specific effects 
(n=8 alcohol+sucrose;n=9 sucrose-only mice). Open-field activity was measured in 
Plexiglas chambers (27.9 cm2; ENV-510, Med Associates) that recorded X-Y ambulatory 
movements. Mice habituated to the open-field for 2-hrs. One week later, mice were given a 
sham injection and placed in the open-field for 1-hr. Subsequently, KN-93 (0 or 1.0 μg) was 
microinjected in a counterbalanced design, with one week separating each test (2 injections/
mouse).
Two-way RM ANOVA (DOSE × TIME) was used to assess dose- and time-dependent 
effects of KN-93 (0 – 10 μg) microinjection on operant response rate and dose consumed 
expressed as cumulative responses per 5-min. Total response data were analyzed by one-
way RM ANOVA. Dunnett’s multiple-comparison test was conducted when appropriate. A 
Pearson product-moment correlation was run to analyze the BAC data. The α level was set 
at 0.05 for all statistical tests.
Infusion of the CAMKII inhibitor KN-93 altered alcohol+sucrose reinforced responding in a 
time- and dose-dependent manner, and an interaction between the two factors was also 
evident. Specifically, cumulative alcohol+sucrose responses increased as a function of time 
(F11,88=118.5;p<0.0001;Figure 1D) indicating continued self-administration throughout the 
session. The effects of KN-93 depended on time as indicated by a significant dose × time 
interaction (F33,264=3.656;p<0.001;Figure 1D). Post-hoc analysis indicated that KN-93 
(1.0μg) infusion in the PFC significantly increased the rate of alcohol+sucrose reinforced 
responding at all time points (0–60 min) as compared to vehicle. KN-93 (0.3μg) transiently 
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increased alcohol+sucrose reinforced response rate (15-25 min) as compared to vehicle, but 
showed a reduction later in the session (55-60 min). Finally, KN-93 (10μg) increased 
response rate during most of the session (15-45 and 55-60 min). Summary analysis of total 
number of alcohol+sucrose reinforced responses showed a main effect of KN-93 dose 
(F3,24=2.957;p=0.05) with a significant overall increase evident following the 1.0 μg dose 
(Figure 1E). Alcohol consumption followed a similar pattern after infusion of vehicle and 
multiple doses of KN-93. The average alcohol dose consumed after aCSF injection was 
1.0±0.09 g/kg/1-hr. Statistically, the dosage of alcohol (g/kg) consumed increased as the 
session progressed (F11,88=151.6;p<0.0001). There was a main effect of KN-93 on dose 
consumed (F3,24=3.525;p=0.03) and the effects of KN-93 on dose consumed changed as a 
function of time (F33,264=5.099;p<0.0001). The effect of KN-93 infusion into the PFC for 
this measurement paralleled what was observed for response rate. Namely, intra-PFC KN-93 
(1.0μg) increased the dose that was consumed within the first 5 min of the self-
administration session and persisted throughout the session whereas increased consumption 
after KN-93 (10μg) emerged and persisted from min 15-60. The lowest dose of KN-93 
(0.3μg) reduced consumption during the last 15 min of the session. Importantly, inactive 
lever responding was not altered by KN-93 and most responses (87.9±2.5%) occurred on the 
active lever.
For sucrose-only self-administering mice, infusion of KN-93 into the mPFC of led to a 
significant main effect of time, and an interaction between time and dose. Specifically, 
responding on the active lever significantly increased as the session progressed 
(F11,110=104.2;p<0.0001;Figure 1G) and an interaction (F33,330=3.494;p<0.001;Figure 1G) 
revealed that KN-93 (10 μg) significantly reduced active lever responding as compared to 
vehicle (5-60 min). KN-93 (1.0 μg) infusion in the mPFC reduced responding sucrose-only 
reinforced responding during the last ten min of the session (50-60 min). Inactive lever 
responses were not affected and the majority of responses occurred on the active lever (85.3 
± 4.0% active lever responding). Summary analysis of total active lever responding showed 
that KN-93 did not alter sucrose-only reinforced responding (Figure 1H).
Importantly, neither experimental group (alcohol+sucrose or sucrose-only) showed altered 
locomotor activity after infusion of KN-93 (1.0 μg, Figure 1F&1I), indicating that drug 
effects on operant responding were not associated with reductions in motor ability.
CAMKII signaling is required for synaptic plasticity [5] and it is increasingly evident that 
this signaling pathway regulates the positive reinforcing effects of alcohol [3], which are 
prominent in the initial stages of addiction. In this study, we discovered that inhibition of 
CaMKII in the mPFC increased the positive reinforcing effects of sweetened alcohol versus 
parallel sucrose-only control. Timecourse data indicated that all doses of KN-93 increased 
alcohol+sucrose reinforced responding at some point during the 1-h session. Interestingly, 
increases in response rate after infusion of KN-93 (1.0 or 10 μg) emerged during the first 
5-15 min of the operant session suggesting that CaMKII inhibition may have increased 
motivation, or conditioned reinforcement, prior to the direct CNS pharmacological effects of 
consumed alcohol. Alternatively, KN-93 may have inhibited the activation of CaMKII that 
occurs during alcohol self-administration (e.g., [3]), which could increase intake in an 
attempt to achieve a desired pharmacological effect. Both the initial increase and persistence 
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of the drug effect over time are consistent with known functions of the mPFC, and suggests 
that CaMKII activity in this brain region may exert top-down inhibition, or dampening, of 
alcohol reinforcement in non-dependent mice. Importantly, these data are consistent with 
our recent finding that inhibition of extracellular-related protein kinase (ERK), a 
downstream target of CAMKII, in the mPFC significantly increased operant responding for 
alcohol+sucrose [16] suggesting similar dampening of alcohol reinforcement by ERK 
signaling. It will be important to evaluate regulation by this system following dependence, 
when inhibitory regulation may be diminished.
KN-93 (1 and 10 μg) infusion in the mPFC reduced sucrose-only reinforced response rate 
during the last 15 min of the self-administration session, which is consistent with blunted 
sucrose preference seen in global αCAMKIIT286A knockout mice [18]. This suggests that 
CaMKII activity in the mPFC may regulate motivation to consume sucrose. However, 
KN-93 (0.3 μg) also reduced alcohol+sucrose reinforced response rate during the last 10-min 
of the session after an initial increase during early time points. The delayed nature of these 
reductions in self-administration may reflect diffusion to adjacent nuclei or downstream 
effects of CaMKII inhibition that are not reinforcer specific.
CAMKII plays an integral role in glutamate neurotransmission throughout the brain [19, 
20]. Growing evidence indicates that glutamate neurocircuitry regulates alcohol drinking, 
reinforcement and relapse in multiple species [3, 10, 11, 21, 22]. In vitro, chronic alcohol 
exposure increases CAMKII activity and glutamate reuptake in cortical astrocytes; this 
effect is blocked with KN-93 suggesting that cortical CAMKII activity is glutamate-
dependent [23]. Moreover, CAMKII interacts with the GluA1 of the AMPA receptor to 
facilitate LTP thereby enhancing excitability and prolonging channel conductance [24]. In 
the amygdala, we previously found that alcohol drinking increases both GluA1 and CAMKII 
phosphorylation, and operant responding for alcohol is decreased by CAMKII inhibition and 
by AMPA receptor antagonism [3]. Likewise, we demonstrated a functional link between 
CAMKII and AMPA in the amygdala; positive modulation of the AMPA receptor activity 
potently increased operant responding for alcohol, which was blocked by CAMKII 
inhibition [25]. A natural extension of the present findings would be to determine if 
glutamate transmission in the mPFC regulates alcohol self-administration in a CaMKII-
dependent manner.
It is intriguing that pharmacological inhibition of CAMKII in the mPFC increased 
sweetened alcohol self-administration in this study but has the opposite effect in the 
amygdala [3]. Since both the amygdala and mPFC send CaMKII-positive glutamatergic 
projections to the nucleus accumbens, these results may reflect CaMKII involvement in the 
differential motivational and executive control over alcohol self-administration exerted by 
these converging neural circuits [15]. Thus, alcohol use upregulates CaMKII activity in the 
amygdala as previously shown [3], and we propose that this may lead to increased 
glutamate-dependent neural activity in the nucleus accumbens, which may increase alcohol-
reinforced responding. By contrast, CaMKII-positive glutamatergic projections from the 
mPFC to nucleus accumbens may inhibit alcohol self-administration via reduced positive 
reinforcement. Although we did not measure the effects of alcohol on CAMKII activity 
(e.g., phosphorylation), we predict that CAMKII phosphorylation would be downregulated 
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in the mPFC after alcohol self-administration. Since enhancement of motivational drive and 
blunted executive control are hallmark properties of alcohol dependence, it will be of critical 
importance to evaluate CaMKII activity in these brain regions and circuits following the 
development of dependence.
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RESEARCH HIGHLIGHTS
• CAMKII activity is important for neural plasticity and development of drug 
addiction
• Moderate alcohol drinking alters CaMKII expression and phosphorylation in the 
CNS
• Pharmacological inhibition of CAMKII in the PFC increases lever-press 
responding reinforced by sweetened alcohol
• The PFC may dampen drug use via top-down control of limbic motivational 
brain regions
Faccidomo et al. Page 9
Behav Brain Res. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
FIGURE 1. 
(A) Experimental timeline. (B) Significant correlation (R2=0.749) between individual 
alcohol dose consumed (g/kg;x-axis) and blood alcohol content (BAC,y-axis). (C) 
Photomicrograph showing the bottom of the guide cannula and injection site from a coronal 
mouse brain section. Schematic shows injection sites for all mice that were included in 
microinjection studies. (D&G) Response rate plotted as cumulative number of active lever 
presses per 5-min interval (Mean±SEM). Open circles represent vehicle performance and 
filled symbols represent each dosage of KN-93. Statistically significant dose-effects at each 
time point are indicated by the following symbols: * (1μg), ^ (0.3μg), and + (10 μg), p<0.05 
versus vehicle. (E-F; H-I) Vertical bars represent total active lever presses in a 1-hr self-
administration session, or horizontal distance traveled (cm/1-hr) in an open-field locomotor 
test, respectively. White bars reflect behavior after Veh infusion. Black bars reflect behavior 
after infusion of KN-93. * - indicates significantly different from vehicle, p<0.05. Data are 
plotted as Mean±SEM.
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